Moreover, in rodent and cell culture models, liraglutide, exendin-4, and GLP-1 reduced pathological findings characteristic of DKD, including mesangial expansion and cell proliferation, glomerular hypertrophy, and tubulointerstitial and glomerular fibrosis [54,55,56,70]. This evidence concerns the gene GCG and diabetic kidney disease.